Medicofarma Biotech SA

Equities

MDB

PLINBOK00010

Biotechnology & Medical Research

End-of-day quote Warsaw S.E. Other stock markets 03:30:00 14/06/2024 am IST			5-day change	1st Jan Change
0.666 ^PLN	+4.06%		-15.05%	-38.62%

13/05	Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
06/02	Medicofarma Biotech SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Medicofarma Biotech SA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023

February 07, 2024 at 03:28 am IST

Medicofarma Biotech SA reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was PLN 0.44 million compared to PLN 45.4 million a year ago. Net loss was PLN 103.88 million compared to PLN 31.41 million a year ago.

Latest news about Medicofarma Biotech SA

Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05	CI
Medicofarma Biotech SA Reports Earnings Results for the Full Year Ended December 31, 2023	07/02	CI
Medicofarma Biotech SA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07/02	CI
Medicofarma Biotech SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Medicofarma Biotech SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2023	13/23/13	CI
Medicofarma Biotech SA Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	14/23/14	CI
Medicofarma Biotech SA Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14	CI
Medicofarma Biotech SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Medicofarma Biotech SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	01/22/01	CI
Medicofarma Biotech SA Reports Earnings Results for the First Quarter Ended March 31, 2022	12/22/12	CI
Medicofarma Biotech SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	04/22/04	CI
Medicofarma Biotech SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/21/12	CI
Medicofarma Biotech Sa Reports Earnings Results for the Second Quarter Ended June 30, 2021	13/21/13	CI
Medicofarma Biotech S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	15/21/15	CI
INBOOK S.A. will Change its Name to Medicofarma Biotech S.A	19/21/19	CI
ABS Investment SA acquired 5.4% stake in Inbook Spólka Akcyjna from INVESTcon GROUP Spolka Akcyjna, Asset Management Arm.	01/16/01	CI
ABS Investment SA acquired 3.4% stake in Inbook Spólka Akcyjna.	30/15/30	CI
Slawomir Jarosz acquired 13.12% stake in Inbook Spólka Akcyjna.	09/14/09	CI

Chart Medicofarma Biotech SA

Duration

Period

More charts

Company Profile

Medicofarma Biotech SA, formerly InBook SA, is a Poland-based biotechnology company. It is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MEDICOFARMA BIOTECH SA	-38.62%	1.11Cr
MODERNA, INC.	+39.72%	5.37TCr
LONZA GROUP AG	+33.67%	3.89TCr
IQVIA HOLDINGS INC.	-7.97%	3.88TCr
CELLTRION, INC.	-10.77%	2.73TCr
ICON PUBLIC LIMITED COMPANY	+11.61%	2.59TCr
ALNYLAM PHARMACEUTICALS, INC.	-17.13%	2.03TCr
UNITED THERAPEUTICS CORPORATION	+34.59%	1.28TCr
MEDPACE HOLDINGS, INC.	+29.48%	1.22TCr
BIO-TECHNE CORPORATION	-2.99%	1.2TCr

Other Biotechnology & Medical Research